Presentation is loading. Please wait.

Presentation is loading. Please wait.

Endoscopic therapies for obesity

Similar presentations


Presentation on theme: "Endoscopic therapies for obesity"— Presentation transcript:

1 Endoscopic therapies for obesity
Christen Klochan Dilly, MD, MEHP Roudebush VA Medical Center Indiana University School of Medicine

2 Objectives Define overweight and obese
List available therapies for obesity Discuss factors considered when selecting a therapy for a patient Understand the role of endoscopic therapies in the management of obesity Recommend appropriate therapy to a patient

3 Disclosures I attended FDA-mandated training paid for by Apollo Endosurgery Videos may be produced by companies or physicians paid by companies Showing them for demonstration of procedure only

4 Obesity “Obesity is defined as a chronic, relapsing, multi-factorial, neurobehavioral disease, wherein an increase in body fat promotes adipose tissue dysfunction and abnormal fat mass physical forces, resulting in adverse metabolic, biomechanical, and psychosocial health consequences.” Obesity Medicine Association, Obesity Algorithm

5 >=40 Class III obesity
Body mass index Ratio of weight to height (kg/m2) <18.5 Under-weight Normal weight Over-weight  Class I obesity Class II obesity >=40 Class III obesity BMI Categories: 

6 Prevalence of self-reported obesity in the US, 2017

7 Obesity is a multifactorial disease
Environment (sociocultural factors) Immune/ microbiota/ infections Lack of physical activity Genetics/ epigenetics Suboptimal nutrition Medical factors Sleep disruption Stress Environment – geographic location, home environment, cultural practices Medical factors – adverse effects of medications, physical limitations Obesity Medicine Association

8 Clinical manifestations of obesity
Cardio-vascular CHF HTN Clots Pulmo-nary OSA OHS Asthma Neuro-psych Pseudo-tumor cerebri Depres-sion Musculo-skeletal OA Low back pain Gout Endo-crine Insulin resistance, DM2 Dys-lipidemia Infertility Gastro-intestinal GERD NAFLD Hernias Gallstones Renal Stones CKD

9 How much weight loss is needed?
Excess body weight = total body weight – lean body weight =fat mass Ideal body weight (within 20%) 5-10% decrease in total body weight provides meaningful health benefits Unrealistic expectations about weight loss Reasonable goal is 10% in first six months Numeracy issues Hamwi method for IBW M = 106 lb for the first 5 ft + 6 lb for each additional inch. M = 48 kg for the first cm kg for each additional cm. F = 100 lb for the first 5 ft + 5 lb for each additional inch. F = 45 kg for the first cm kg for each additional cm.

10 Exercise, Diet, Behavioral Modification Endoscopic Procedures
Obesity Treatment BMI kg/m2 Exercise, Diet, Behavioral Modification Medication Bariatric Surgery Endoscopic Procedures 25 X 27 X* 30 35 40 * With comorbidity Ashley Gilmore, IUSM UDOS course

11 Weight loss options Intensive lifestyle modification Pharmacotherapy
Nutrition counselling Exercise Behavioral therapy Pharmacotherapy Endobariatric interventions Surgical options

12 Intensive lifestyle modification
Heymsfield & Wadden, NEJM 2017

13 Pharmacotherapy Drug MOA Side effects Phentermine Stimulant
Hypertension, palpitations Orlistat Impairs fat absorption Oily discharge, fat-solube vitamin deficiencies Lorcaserin (Belviq) SSRI – affects areas of brain involved with cognition, mood, appetite minimal Liraglutide Slows gastric emptying Nausea/vomiting, fullness Naltrexone/buproprion (Contrave) Blunts pleasurable response to eating, reduces food intake Nausea/vomiting, diarrhea, risk of suicide in young adults Phentermine/topiramate (Qsymia) Adds anticonvulsant – increased energy expenditure & appetite suppression Some psychiatric side effects, risk of birth defects

14 Weight loss with drugs is similar to intensive lifestyle modification
Heymsfield & Wadden, NEJM 2017

15 Surgical options Restrictive Malabsorptive Gastric band
Sleeve gastrectomy Roux-en-y gastric bypass Malabsorptive Duodenal switch/biliopancreatic diversion

16 Laparoscopic adjustable gastric band
Excess weight loss 33-64% 15-20% of total body weight 250-lb person may lose 50 lbs DeMaria, NEJM 2007

17 Endoscopy after lap band
Erosion of band Food impactions Galvo Neto et al, Surgery for Obesity and Related Diseases, 2010

18 Vertical sleeve gastrectomy
Excess weight loss 19-97% (mean 57%) 25% of total body weight at one year 250-lb person may lose lbs

19 Roux-en-Y gastric bypass
Excess weight loss 70-92% Total body weight 30% at one year 250-lb person may lose 75 lbs Dumping syndrome Vitamin deficiencies

20 Endoscopy after bypass
Anastomotic ulcers Bleeding in the excluded stomach Need for ERCP Endoscopic reduction of gastric pouch video

21 Biliopancreatic diversion with duodenal switch
More weight loss Many more complications Rare

22 Issues with surgery Invasive Risk of complications
Marginal ulcers Anastomotic strictures or leaks Bleeding – 0.5% Wound infections – 1.8% Blood clots – 0.8% Anesthesia complications – 6.1% Incisional/internal hernias Death – % Risk of weight regain

23 Intragastric balloon BMI 30-40 ~25% excess weight loss
5.9% total body weight loss About 20 lbs

24 Intragastric balloon video

25 Intragastric balloon - contraindications
Prior GI or bariatric surgery Large hiatal hernia Severe or uncontrolled GERD Anatomic abnormalities of the GI tract Inflammation or ulcers of the GI tract Potential for GI bleed (AVM, varices) Coagulopathy Use of NSAIDs Serious or uncontrolled psychiatric illness Binge eating disorder Alcoholism or drug addiction Unwilling to participate in diet & behavior modification program Pregnancy or breastfeeding Cirrhosis Gastric or esophageal motility disorder

26 Intragastric balloon - risks
Early intolerance Endoscopy-related complications Migration Hyperinflation Acute gastric distention Ulcerations Pancreatitis Death – 2/10,000

27 Roudebush VA process 3-6 months GI clinic Balloon placed 6 months
MOVE program psych eval GI clinic Explain options Balloon placed Daily nurse call 6 months MOVE Monthly GI Balloon out Every other month GI

28 Endoscopic sleeve gastroplasty
video Abu Dayyeh, CGH 2017

29 Endoscopic sleeve gastroplasty
BMI 30-40 About 50% excess weight loss at 1 year Similar to lap band Off-label use of the Overstitch device

30 AspireAssist video Thompson et al, AJG 2016

31 AspireAssist BMI 35-55 14.2% total body weight loss
45-60% excess weight loss Must chew food thoroughly Thompson et al, AJG 2016

32 Case 1 60-year-old man with hypertension and hyperlipidemia BMI 34
Well-controlled GERD No prior abdominal surgeries Lost 30 lbs with intensive lifestyle modification What weight loss therapies would you recommend?

33

34 Case 2 30-year-old man with hypertension, obstructive sleep apnea, non- alcoholic fatty liver BMI 38 No success with several weight loss methods No physical activity Forgets diet records at every visit Possible binge eating disorder What weight loss therapies would you recommend?

35

36 Case 3 55-year-old woman with obesity BMI 43
No prior abdominal surgeries Well-controlled depression What weight loss therapies would you recommend?

37

38 Case 4 45-year-old woman with type 2 diabetes BMI 35
On insulin and metformin History of deep vein thrombosis What weight loss therapies would you recommend?

39

40 Take-home messages Obesity is a major public health issue
Losing 5-10% of body weight can be enough to provide health benefits Intensive lifestyle modification is a life-long commitment that requires a team approach Registered (bariatric) dietitian, behavioral psychologist, physician Pharmacotherapy can be helpful alone or in combination with other therapies Bariatric surgery is recommended for BMI >40 Endoscopic bariatric therapies can help “boost” weight loss for BMI 30-40


Download ppt "Endoscopic therapies for obesity"

Similar presentations


Ads by Google